BioNTech
initiated phase trial for our agonist in | BioNTech
Company
Deck Type
Sector
Industry
Deck date
August 2020
Slide
16 of 28
Related slides by other companies
Ocuphire Pharma
Results
June 2021
next steps advance into phase presbyopia registration trials in towards a potential in | Ocuphire Pharma
AstraZeneca
Results
February 2024
investing in new launches near and mid term pipeline phase trials initiated across medicines phase trials initiated with blockbuster potential regulatory approvals in major markets new medicines approved and on track to deliver on ambition for at least launches by | AstraZeneca
AstraZeneca
Results
February 2025
significant progress with transformative technologies to drive growth | AstraZeneca
MindMed
Investor Presentation
November 2024
key highlights of program | MindMed
Other recent decks by BioNTech
See all presentations (12 decks)
Investor Presentation
August 2022
Results
August 2022
Investor Day
June 2022
Results
March 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io